Benchmarking ambulance call-to-needle times for thrombolysis after acute myocardial infarction in Australia: a pilot study

被引:3
作者
Kelly, AM
Kerr, D
Patrick, I
Walker, T
机构
[1] Univ Melbourne, Dept Med, Melbourne, Vic, Australia
[2] Metropolitan Ambulance Serv, Melbourne, Vic, Australia
[3] Western Hosp, Joseph Epstein Ctr Emergency Med Res, Melbourne, Vic, Australia
关键词
benchmark; mortality; myocardial infarction; thrombolysis;
D O I
10.1046/j.1444-0903.2001.00197.x
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background: Thrombolysis for patients with acute myocardial infarction (AMI) is of greatest benefit when treatment is commenced as soon as possible after symptom onset. The British Heart Foundation (BHF) recently set a benchmark recommending that eligible patients with AMI receive thrombolytic therapy less than 90 min after calling for medical assistance. Aims: The purpose of this study was to compare the performance of an urban emergency service to this benchmark. A secondary objective was to determine whether patients treated outside this time were at a greater risk of mortality. Methods: This study consisted of an explicit retrospective analysis of medical records for all patients who presented by ambulance to the Emergency Department (ED) of Western Hospital and received thrombolysis for AMI within 12 h of symptom onset. The study was conducted for the 18-month period between 1 January 1999 and 30 June 2000. Information collected included times of: (i) symptom onset, (ii) call for ambulance, (iii) ambulance response, (iv) transport to hospital and (v) thrombolysis, as well as final diagnosis and in-hospital mortality. For the purposes of this study, call-to-needle time (CTN) was defined as the time between calling the ambulance and commencement of thrombolytic therapy. Results: One hundred and twenty-seven patients met the inclusion criteria. Median CTN was 81 min (range 42-279 min). Sixty-four per cent of patients were treated within the 90-min benchmark. The relative risk of mortality for patients treated outside the 90-min benchmark was 2.6 (95% CI 0.98-6.72). Conclusion: This study showed that the BHF benchmark for CTN was not being met for over one-third of patients in the study region, with potential impact on mortality after AMI. Further research is needed to establish: (i) whether there is relationship between longer transportation times and mortality, (ii) whether the findings of this study may be applied to other regions and (iii) what strategies might be employed to reduce CTN.
引用
收藏
页码:138 / 142
页数:5
相关论文
共 25 条
[1]  
[Anonymous], 1987, LANCET, V2, P871
[2]  
[Anonymous], 1988, LANCET, V2, P349
[3]  
[Anonymous], 1986, LANCET, V1, P397
[4]   INDICATIONS FOR FIBRINOLYTIC THERAPY IN SUSPECTED ACUTE MYOCARDIAL-INFARCTION - COLLABORATIVE OVERVIEW OF EARLY MORTALITY AND MAJOR MORBIDITY RESULTS FROM ALL RANDOMIZED TRIALS OF MORE THAN 1000 PATIENTS [J].
APPLEBY, P ;
BAIGENT, C ;
COLLINS, R ;
FLATHER, M ;
PARISH, S ;
PETO, R ;
BELL, P ;
HALLS, H ;
MEAD, G ;
DIAZ, R ;
PAOLASSO, E ;
PAVIOTTI, C ;
ROMERO, G ;
CAMPBELL, T ;
OROURKE, MF ;
THOMPSON, P ;
LESAFFRE, E ;
VANDEWERF, F ;
VERSTRAETE, M ;
ARMSTRONG, PW ;
CAIRNS, JA ;
MORAN, C ;
TURPIE, AG ;
YUSUF, S ;
GRANDE, P ;
HEIKKILA, J ;
KALA, R ;
BASSAND, JP ;
BOISSEL, JP ;
BROCHIER, M ;
LEIZOROVICZ, A ;
BRUGGEMANN, T ;
KARSCH, KR ;
KASPER, W ;
LAMMERTS, D ;
NEUHAUS, KL ;
MEYER, J ;
SCHRODER, R ;
VONESSEN, R ;
SARAN, RK ;
ARDISSINO, D ;
BONADUCE, D ;
BRUNELLI, C ;
CERNIGLIARO, C ;
FORESTI, A ;
FRANZOSI, MG ;
GUIDUCCI, D ;
MAGGIONI, A ;
MAGNANI, B ;
MATTIOLI, G .
LANCET, 1994, 343 (8893) :311-322
[5]  
Australian Institute of Health and Welfare, 2001, CARD DIS SER
[6]   Trends in the provision of thrombolytic treatment between 1993 and 1997 [J].
Birkhead, JS .
HEART, 1999, 82 (04) :438-442
[7]   Australian patients' delay in response to heart attack symptoms [J].
Dracup, K ;
McKinley, SM ;
Moser, DK .
MEDICAL JOURNAL OF AUSTRALIA, 1997, 166 (05) :233-236
[8]   EFFECT OF REPERFUSION ON ELECTROCARDIOGRAPHIC AND ENZYMATIC INFARCT SIZE - RESULTS OF A RANDOMIZED MULTICENTER STUDY OF INTRAVENOUS ANISOYLATED PLASMINOGEN STREPTOKINASE ACTIVATOR COMPLEX (APSAC) VERSUS INTRACORONARY STREPTOKINASE IN ACUTE MYOCARDIAL-INFARCTION [J].
HACKWORTHY, RA ;
SORENSEN, SG ;
FITZPATRICK, PG ;
BARRY, WH ;
MENLOVE, RL ;
ROTHBARD, RL ;
ANDERSON, JL .
AMERICAN HEART JOURNAL, 1988, 116 (04) :903-914
[9]  
*HEART FDN AUSTR, 2000, GUID REP THER AC MYO
[10]   Delays in thrombolytic therapy for acute myocardial infarction in Finland - Results of a national thrombolytic therapy delay study [J].
Hirvonen, TPJ ;
Halinen, MO ;
Kala, RA ;
Olkinuora, JT .
EUROPEAN HEART JOURNAL, 1998, 19 (06) :885-892